China Builds a Faster Beagle in Gene-Editing Race With U.S
By Bloomberg News,
Bloomberg News
| 02. 23. 2016
U.S. companies racing to develop a promising gene editing technology are up against a formidable competitor -- the Chinese government.
China has long set its heart on building an expertise in genomics and its government is pouring funds into a new -- and sometimes controversial tool -- called Crispr, encouraging its researchers to advance the technology. Chinese scientists say they were among the first in using Crispr to make wheat resistant to a common fungal disease, dogs more muscular and pigs with leaner meat.
The scientific research bankrolled by the Chinese government could eventually be tapped by agricultural and pharmaceutical companies. Programs funded by Beijing are, among other things, working on disease-resistant tomatoes, breast cancer treatments and increasing the oil content in soy beans. In the southern city of Guangzhou, researchers who received government funds went a step further, sparking an international ethical debate last year after tweaking the genetic make up of human embryos using Crispr for the first time.
Formally called Crispr-Cas9, the genetic editing tool acts like a pair of low-cost and highly precise molecular scissors that can cut...
Related Articles
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
By Amanda Becker and Shefali Luthra, The 19th | 07.08.2024
Image by Duke University Archives from Flickr
Republicans have adopted a slate of policy positions ahead of next week’s convention that does not call for a federal legislative abortion ban, but opens the door to establishing fetal personhood.
The Republican...
By Beth Duff-Brown, Stanford Institute for Economic Policy Research | 07.12.2024
The debate over in vitro fertilization (IVF) has become a hot-button policy and political issue, despite the medical procedure to help people become pregnant having been mainstream in the United States for nearly half a century.
The Alabama Supreme Court ...
By Gilma Avalos, NBC | 07.03.2024
Image by Josh Appel from Unsplash
The dream of becoming parents is turning into a nightmare for hundreds of people caught up in a surrogacy money scandal.
Some of the individuals are facing infertility or medical challenges, seeing surrogacy as...